Johnson & Johnson to pay $72m in case linking baby powder to ovarian cancer
Jury in Missouri orders pharmaceutical company to pay damages to
family of deceased woman who claimed talcum powder caused her cancer
A bottle of Johnson & Johnson’s baby powder.
Photograph: Sean Gibson for the Observer
Associated Press
A Missouri
jury has awarded $72m to the family of a woman who died from ovarian
cancer, which she said was caused by using Johnson & Johnson’s baby
powder and other products containing talcum.
The civil suit by Jackie Fox of Birmingham, Alabama,
was part of a broader claim in the city of St. Louis circuit court
involving nearly 60 people. Her son took over as plaintiff following his
mother’s October 2015 death at 62, more than two years after her
diagnosis.
Marvin Salter of Jacksonville, Florida, said his late mother, who
was a foster parent, used the brand of talcum powder as a bathroom
staple for decades. “It just became second nature, like brushing your
teeth,” he said. “It’s a household name.”
Mute
Current Time 0:00
/
Duration Time 1:24
Loaded: 0%
Progress: 0%
Pinterest
The
attorney representing the family of a woman whose death from ovarian
cancer was linked to her use of Johnson & Johnson products says the
company knew the risks
An attorney for Fox said the jury verdict Monday night, which came
after nearly five hours of deliberations at the conclusion of a
three-week trial, was the first such case among more than 1,000
nationally to result in a jury’s monetary award.
The jury said that Fox was entitled to $10m in actual damages and
$62m in punitive damages. Attorney James Onder said he “absolutely”
expects Johnson & Johnson – the world’s biggest maker of healthcare
products – to appeal the verdict.
The New Jersey-based company previously has been targeted by health
and consumer groups over possibly harmful ingredients in items including
in its Johnson’s No More Tears baby shampoo.
In May 2009, a coalition of groups called the Campaign for Safe Cosmetics
began pushing Johnson & Johnson to eliminate questionable
ingredients from its baby and adult personal care products. After three
years of petitions, negative publicity and a boycott threat, the company
agreed in 2012 to eliminate the ingredients 1,4-dioxane and
formaldehyde, both considered probable human carcinogens, from all
products by 2015.
Spokeswoman Carol Goodrich said that the company was considering its
next legal move. In a written statement, she said the verdict “goes
against decades of sound science proving the safety of talc as a
cosmetic ingredient in multiple products,” citing supportive research by
the US Food and Drug Administration and National Cancer Institute.
In the trial, Fox’s attorneys introduced into evidence a September
1997 internal memo from a Johnson & Johnson medical consultant
suggesting that “anybody who denies [the] risks” between “hygenic” talc
use and ovarian cancer would be publicly perceived in the same light as
those who denied a link between smoking cigarettes and cancer: “Denying
the obvious in the face of all evidence to the contrary.”
Advertisement
Talc is a naturally occurring mineral, mined from the soil and composed
of magnesium, silicon, oxygen, and hydrogen. It is widely used in
cosmetics and personal care products, such as talcum powder, to absorb
moisture, prevent caking and improve the product’s feel.
Nora Freeman Engstrom, a Stanford University law professor not
involved in the Missouri case, said it was unlikely the $72m award would
survive, noting that the US Supreme Court, in a recent series of
rulings, has maintained that appeal courts clamp down on punitive
damages.
“Big jury verdicts do tend to be reined in during the course of the
appellate process, and I expect that to be the case here,” she told
Associated Press.
Monday’s verdict “doesn’t bode well for Johnson & Johnson” as it
faces at least 1,200 still-pending lawsuits and possibly thousands more,
she said.
“This case clearly was a bellwether, and clearly the jury has seen
the evidence and found it compelling,” she said, concluding “the jury
was distressed by the company’s conduct”.
0 komentar:
Posting Komentar